Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Yu

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Frontiers in Neuroscience|June 5, 2023
Multiple sclerosis lesion segmentation: revisiting weighting mechanisms for federated learningDongnan Liu, Mariano Cabezas, Dongang Wang, et al.
World Neurosurgery|March 11, 2022
Impact of Frailty on Morbidity and Mortality in Adult Patients Undergoing Surgical Evacuation of Acute Traumatic Subdural HematomaAladine A Elsamadicy, Mani Ratnesh S Sandhu, Isaac G Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2018
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II TrialHarriet M Kluger, Veronica Chiang, Amit Mahajan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasGuoan Chen, Mahaveer S Bhojani, Andrew C Heaford, et al.
American Journal of Cancer Research|July 16, 2025
The correlation between ALDH2 rs671 polymorphism and clinical prognosis in alcoholic liver disease-related hepatocellular carcinoma after curative resectionChih-Jan Ko, Wen-Lung Wang, Hung-Yu Lin, et al.
Cureus|October 20, 2023
Selected-Lesion Stereotactic Radiosurgery (SL-SRS) as a Novel Strategy in the Treatment of Patients With Multiple Brain MetastasesBrianna C Theriault, Charu Singh, James Yu, et al.
The Lancet. Oncology|June 9, 2016
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trialSarah B Goldberg, Scott N Gettinger, Amit Mahajan, et al.
JCI Insight|January 25, 2019
Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenanceDongwon Choi, Eunkyung Park, Eunson Jung, et al.
Cancers|June 13, 2025
Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant TherapyJames Yu, Jose M Laborde, Robin Park, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Frontiers in Neuroscience|June 5, 2023
Multiple sclerosis lesion segmentation: revisiting weighting mechanisms for federated learningDongnan Liu, Mariano Cabezas, Dongang Wang, et al.
World Neurosurgery|March 11, 2022
Impact of Frailty on Morbidity and Mortality in Adult Patients Undergoing Surgical Evacuation of Acute Traumatic Subdural HematomaAladine A Elsamadicy, Mani Ratnesh S Sandhu, Isaac G Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2018
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II TrialHarriet M Kluger, Veronica Chiang, Amit Mahajan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasGuoan Chen, Mahaveer S Bhojani, Andrew C Heaford, et al.
American Journal of Cancer Research|July 16, 2025
The correlation between ALDH2 rs671 polymorphism and clinical prognosis in alcoholic liver disease-related hepatocellular carcinoma after curative resectionChih-Jan Ko, Wen-Lung Wang, Hung-Yu Lin, et al.
Cureus|October 20, 2023
Selected-Lesion Stereotactic Radiosurgery (SL-SRS) as a Novel Strategy in the Treatment of Patients With Multiple Brain MetastasesBrianna C Theriault, Charu Singh, James Yu, et al.
The Lancet. Oncology|June 9, 2016
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trialSarah B Goldberg, Scott N Gettinger, Amit Mahajan, et al.
JCI Insight|January 25, 2019
Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenanceDongwon Choi, Eunkyung Park, Eunson Jung, et al.
Cancers|June 13, 2025
Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant TherapyJames Yu, Jose M Laborde, Robin Park, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
Pageof 15